Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2014-01-15710,2014,Shepard 2014 PLoS One,17000,"Area-Wide Integrated Pest Management VERSUS None IN Healthy; Age- 0 to 18 years, 41 to 64 years, >=65 years; Gender- Both; Country- United States.",25338065,"Healthy; Age- 0 to 18 years, 41 to 64 years, >=65 years; Gender- Both; Country- United States.",Area-Wide Integrated Pest Management,Economic evaluation of an area-wide integrated pest management program to control the Asian tiger mosquito in New Jersey.,None,NE
2011-01-07367,2011,Chen 2011 Can J Cardiol,24000,Clopidogrel plus aspirin VERSUS Aspirin IN Canadian patients with established cardiovascular disease or multiple cardiovascular risk factors,21459271,Canadian patients with established cardiovascular disease or multiple cardiovascular risk factors,Clopidogrel plus aspirin,Economic Evaluation of Clopidogrel Plus Aspirin for Secondary Prevention of Cardiovascular Events in Canada for Patients With Established Cardiovascular Disease: Results From the CHARISMA Trial.,Aspirin,NE
2009-01-05296,2009,Eckman 2009 Ann Intern Med,210000,Testing for variant alleles involved in warfarin metabolism to allow for more personalized dosing of warfarin during induction phase VERSUS No genotyping for warfarin-related variant alleles and using standard warfarin induction IN Outpatients or inpatients with newly diagnosed nonvalvular atrial fribrulation and no contraindications to warfarin therapy,19153410,Outpatients or inpatients with newly diagnosed nonvalvular atrial fribrulation and no contraindications to warfarin therapy,Testing for variant alleles involved in warfarin metabolism to allow for more personalized dosing of warfarin during induction phase,Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.,No genotyping for warfarin-related variant alleles and using standard warfarin induction,NE
2009-01-05085,2009,Collins 2009 Am J Emerg Med,59000,"Observation unit VERSUS Emergency department discharge IN Patients with acute decompensated heart failure and non-high-risk heart failure, 60 year old men, United States",19328373,"Patients with acute decompensated heart failure and non-high-risk heart failure, 60 year old men, United States",Observation unit,Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure.,Emergency department discharge,NE
2009-01-05085,2009,Collins 2009 Am J Emerg Med,910000,"Hospital admission VERSUS Emergency department discharge IN Patients withacute decompensated heart failure and non-high-risk heart failure, 60 year old men, United States",19328373,"Patients withacute decompensated heart failure and non-high-risk heart failure, 60 year old men, United States",Hospital admission,Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure.,Emergency department discharge,NE
1999-01-02048,1999,Marin 1999 J Occup Environ Med,290000,Post-exposure chemoprophylaxis program with zidovudine alone VERSUS No treatment IN Health care workers with percutaneous exposure to blood,10491791,Health care workers with percutaneous exposure to blood,Post-exposure chemoprophylaxis program with zidovudine alone,Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers,No treatment,NE
1999-01-02048,1999,Marin 1999 J Occup Environ Med,310000,Post-exposure chemoprophylaxis program with standard 3-drug regimen VERSUS No treatment IN Health care workers with percutaneous exposure to blood,10491791,Health care workers with percutaneous exposure to blood,Post-exposure chemoprophylaxis program with standard 3-drug regimen,Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers,No treatment,NE
1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
